Skip to main content

Table 1 Model inputs

From: Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis

Model input

Base case value

Distribution

Transition probabilities

  

W to S

0.097

β(SD: 0.029)

W to A

0.004

β(SD: 0.002)

S to W

0.817

β(SD: 0.038)

S to A

0.007

β(SD: 0.003)

A to W

0.271

β(SD: 0.044)

A to S

0.052

β(SD: 0.046)

Utility

  

Well-controlled

0.99

β(SD: 0.016)

Sub-optimal control

0.70

β(SD: 0.072)

Asthma exacerbation

0.31

β(SD: 0.070)

EO effectiveness

  

Relative risk of reduction of exacerbations

0.57

LogN(SD: 0.20)

FeNO-SC effectiveness

  

Relative risk of reduction of exacerbations

0.76

LogN(SD: 0.274)

  1. W Well-controlled, S sub-optimal control, A asthma exacerbation